Results 51 to 60 of about 1,326 (158)
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
Background Brain PET imaging with different tracers is mainly clinically used in the field of neurodegenerative diseases and brain tumors. In recent years, the potential usefulness of PET has also gained attention in the field of MS.
Matteo Bauckneht +12 more
doaj +1 more source
ABSTRACT Background and Purpose Solitary tumefactive demyelinating lesions (TDLs) represent an uncommon but clinically significant manifestation of central nervous system demyelination and pose a major diagnostic challenge due to their radiologic resemblance to high‐grade gliomas, primary central nervous system lymphoma, and other mass‐like lesions ...
Joga Chaganti +4 more
wiley +1 more source
The Associations Between Chronic Active Lesions and White Matter Disease: A 7 Tesla Imaging Study
ABSTRACT Background The relationship between paramagnetic rim lesions (PRLs) and surrounding normally appearing white matter (NAWM) disease, potentially contributory to the associations seen between PRLs and clinical impairment, is underexplored. Objectives To assess whether PRLs correlate with a greater degree of NAWM injury in early MS.
Ellie McCluey +17 more
wiley +1 more source
Neuroimaging of tumefactive multiple sclerosis with atypical features
Tumefactive demyelinating lesions or tumefactive multiple sclerosis (TMS) constitute a unique presentation of demyelinating disease that frequently mimics intracranial neoplasm, infection or other, nondemyelinating intracranial pathology. Consequently, these lesions, which are larger than typical multiple sclerosis plaques and are generally ...
Koppula, Rohit +5 more
openaire +2 more sources
A Case of Multiple Sclerosis Presenting with Tumefactive Lesions
Inflammatory demyelinating diseases including multiple sclerosis (MS) are usually diagnosed based on characteristic clinical and radiological findings. However, some demyelinating diseases have presented with growing large mass-like lesions, and it is difficult to differentiate those demyelinating lesions from brain tumors.
Yu-jin Kang, Sang-Gon Lee, Suk-Won Ahn
openaire +1 more source
ABSTRACT Background Myelin oligodendrocyte glycoprotein antibody‐associated disease can manifest as a relapsing or monophasic condition. Although several MRI studies have shown evident gray and white matter atrophy compared to healthy controls, little is known about regional brain volume dynamics in myelin oligodendrocyte glycoprotein antibody ...
Theodoros Ladopoulos +10 more
wiley +1 more source
ABSTRACT Tumor Necrosis Factor‐alpha (TNF‐α) inhibitors have been successfully used to treat rheumatoid arthritis (RA), psoriatic and ankylosing arthritis, and inflammatory bowel disease. While these inhibitors effectively decrease the inflammatory activity of immune‐related disorders, they have been associated with central nervous system (CNS) and ...
Shahla Mohammed Saeed Rasul +3 more
wiley +1 more source
The effect of ocrelizumab on Balo's tumefactive lesion: A case report
Balo's concentric sclerosis (BCS) is a rare subtype of multiple sclerosis. Advanced MRI metrics, such as magnetization transfer ratio (MTR), fractional anisotropy (FA), mean diffusivity (MD), and the ratio of total N-acetylaspartate concentration/total ...
Muhammad Faraz Raghib, MD +5 more
doaj +1 more source
We report a 35-year-old healthy male who developed central nervous system inflammatory demyelinating disease consistent with tumefactive multiple sclerosis.
Kristen Lew +8 more
doaj +1 more source
Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists.
Aigli G. Vakrakou +14 more
doaj +1 more source

